Bio-Techne (TECH) Operating Leases (2019 - 2026)

Bio-Techne has reported Operating Leases for 8 years, with the latest figure at $76.1 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 4.16% year-over-year to $76.1 million; the trailing twelve-month figure through Mar 2026 stood at $76.1 million (down 4.16% YoY), and the FY2025 full-year result was $84.0 million, down 4.17% from the prior year.
• Operating Leases for Q1 2026 stood at $76.1 million, down from $77.2 million in the prior quarter.
• The five-year high for Operating Leases was $97.3 million in Q3 2023, with the low at $56.3 million in Q1 2022.
• Average Operating Leases over 5 years is $81.3 million, with a median of $81.6 million recorded in 2024.
• Year-over-year, Operating Leases dropped 15.67% in 2022 and surged 65.52% in 2023.
• Tracing TECH's Operating Leases over 5 years: stood at $78.2 million in 2022, then gained by 22.82% to $96.0 million in 2023, then decreased by 15.01% to $81.6 million in 2024, then declined by 5.43% to $77.2 million in 2025, then dropped by 1.35% to $76.1 million in 2026.
• The last three Operating Leases figures came in at $76.1 million (Q1 2026), $77.2 million (Q4 2025), and $80.7 million (Q3 2025), per Business Quant data.

Peer Comparison